Barbara Klencke

2.7k citations
39 papers · 1.8k indexed · 1 hit paper · h-index 19

Impact in

  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Viral-associated cancers and disorders
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
  • Genetics top 5%
    • Glioma Diagnosis and Treatment

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 9
    • Cancer Treatment and Pharmacology 7
    • HER2/EGFR in Cancer Research 7
    • Colorectal Cancer Treatments and Studies 5
    • Viral-associated cancers and disorders 4

Barbara Klencke

39 papers receiving 1.8k citations

Hit Papers

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy 2010 · 568 citations
5682010202620152020100200300400500

Peers

Barbara Klencke
Comparison fields: 5 of 71
  • Oncology 1.0k
  • Genetics 283
  • Radiology, Nuclear Medicine and Imaging 521
  • Cancer Research 185
  • Immunology 195
Replace E. Lin with:
E. Lin United States
Timothy P. Singleton United States
Carla J. de Boer Netherlands
Emanuela Bonoldi Italy
Dominic Fong Austria
Robert E. Sobol United States
Christian Meyer zum Büschenfelde Germany
Jennifer J.D. Morrissette United States
G Bryant United States
Barry L. Dowell United States
Barbara Klencke relative to E. Lin United States E. Lin's profile →
Citations per field
00.5×3.1×
E. Lin · 1×
Citations per year

Countries citing papers authored by Barbara Klencke

Since Specialization
Citations

This map shows the geographic impact of Barbara Klencke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Klencke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Klencke more than expected).

Fields of papers citing papers by Barbara Klencke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Klencke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Klencke. The network helps show where Barbara Klencke may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Klencke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Klencke Line = papers co-authored together Barbara Klencke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202310
2 202322
3 20231
4 202227
5 202240
6 20213
7 201762
8 201243
9 201156
10 2010104
11 20091
12 200418
13 200345
14 2003107
15 200212
16 200085
17 1999134
18 19981
19 19984
20
Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile.
199641

About Barbara Klencke

Barbara Klencke is a scholar working on Genetics, Oncology, Hematology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Oncology (1.0k citations), Genetics (283 citations), Radiology, Nuclear Medicine and Imaging (521 citations), Cancer Research (185 citations) and Immunology (195 citations). Barbara Klencke has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Howard A. Burris, Hope S. Rugo, R. Borson, Svetislava J. Vukelja, Joyce O’Shaughnessy, Steven Limentani, Sandhya Girish, Elizabeth Tan-Chiu, Ian E. Krop and Charles L. Vogel. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, HemaSphere, Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026